SREA Operating Cash Flow
$5.42BTTM · USD
Period ending:
SREA FY Operating Cash FlowUSD
$6.22B-$287.00M
2001-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
SREA operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 22 observations from Dec 31, 2001 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 4,565,000,000 | |
| 4,907,000,000 | |
| 6,218,000,000 | |
| 1,142,000,000 | |
| 4,208,000,000 | |
| 3,352,000,000 | |
| 3,088,000,000 | |
| 3,516,000,000 | |
| 3,651,000,000 | |
| 2,344,000,000 | |
| 2,920,000,000 | |
| 2,161,000,000 | |
| 1,784,000,000 | |
| 2,018,000,000 | |
| -287,000,000 | |
| -9,000,000 | |
| -7,000,000 | |
| 173,000,000 | |
| 240,000,000 | |
| 322,000,000 | |
| -7,000,000 | |
| 475,000,000 |
Compare operating cash flow
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) operating cash flow
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) operating cash flow
- Novartis AG Common Stock (NVS) operating cash flow
- Royal Bank Of Canada Common Stock (RY) operating cash flow
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) operating cash flow
- SAP SE ADS (SAP) operating cash flow
- AstraZeneca PLC Ordinary Shares (AZN) operating cash flow
- Toyota Motor Corporation Common Stock (TM) operating cash flow
All SREA financial metrics · SREA stock overview · How to interpret financial metrics
